Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Carboxylic acids and derivatives >  1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine

1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine

Basic information Safety Supplier Related

1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine Basic information

Product Name:
1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine
Synonyms:
  • 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYL-4-OXOPIPERIDINE
  • tert-butyl 3,3-dimethyl-4-oxopiperidine-1-carboxylate
  • 1-Piperidinecarboxylic acid, 3,3-diMethyl-4-oxo-, 1,1-diMethylethyl ester
  • 1,1-Dimethylethyl 3,3-dimethyl-4-oxo-1-piperidinecarboxylate
  • 1-tert-Butoxycarbonyl-3,3-dimethyl-4-piperidone
  • 1-tert-Butyloxycarbonyl-3,3-dimethyl-4-piperidone
  • 3,3-Dimethyl-4-oxo-1-piperidinecarboxylic acid tert-butyl ester
  • tert-butyl 3,3-diMethyl-4-oxopiperidine-1-carb
CAS:
324769-06-4
MF:
C12H21NO3
MW:
227.3
Mol File:
324769-06-4.mol
More
Less

1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine Chemical Properties

Boiling point:
303℃
Density 
1.035
Flash point:
137℃
storage temp. 
2-8°C
pka
-1.51±0.40(Predicted)
form 
solid
color 
off white
InChI
InChI=1S/C12H21NO3/c1-11(2,3)16-10(15)13-7-6-9(14)12(4,5)8-13/h6-8H2,1-5H3
InChIKey
MXCAGVCUIHYAGH-UHFFFAOYSA-N
SMILES
N1(C(OC(C)(C)C)=O)CCC(=O)C(C)(C)C1
More
Less

Safety Information

HazardClass 
IRRITANT
HS Code 
2933399990
More
Less

1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine Usage And Synthesis

Uses

1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine can be used as organic synthesis intermediates and pharmaceutical intermediates.

Synthesis

24424-99-5

173186-91-9

324769-06-4

General procedure for the synthesis of 1-BOC-3,3-dimethyl-4-oxopiperidine from di-tert-butyl dicarbonate and 3,3-dimethyl-1-phenylmethyl-piperidin-4-one: 10.14 g (46.66 mmol) of 1-benzyl-3,3-dimethyl-4-oxo-piperidine, 1.03 g of 10% palladium-carbon catalyst and 11.09 g (50.81 mmol) of di- di-tert-butyl carbonate were dissolved in 210 mL of methanol. The mixture was purged three times with nitrogen and then three times with hydrogen. Subsequently, the mixture was subjected to 50 psig hydrogen pressure and the reaction was shaken at room temperature for 16 hours. Upon completion of the reaction, the reaction mixture was filtered through a bed of diatomaceous earth and glass microfiber filter paper. The filtrate was concentrated under reduced pressure and the residue was purified by silica gel column chromatography using hexane containing 20% ethyl acetate as eluent. The elution grade containing the target product was collected and concentrated under reduced pressure to give 9.38 g (88.5% yield) of 1-(tert-butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine.

References

[1] Patent: EP1204659, 2003, B1. Location in patent: Page/Page column 27
[2] Patent: EP1204660, 2004, B1. Location in patent: Page 18
[3] Patent: EP1204660, 2004, B1. Location in patent: Page 16-17
[4] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 10, p. 1627 - 1629
[5] Patent: US2002/169155, 2002, A1

1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidineSupplier

Wuxi InterpiPharm, Inc. Gold
Tel
510-83782303 13771177691
Email
sales@itppharm.com
Suzhou BEC Biological Technology Co., Ltd Gold
Tel
+86-512-68095917 17712685869
Email
sales@bek.com.cn
Shanghai Send Pharmaceutical Technology Co., Ltd. Gold
Tel
+86-021-50266790 Q2086672224
Email
sale@shsendpharm.com
Shanghai AQBioPharma Co., Ltd. Gold
Tel
13661411401
Email
yinglv.que@aqbiopharma.com.cn
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com